Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 667 | 612 | 647 | 532 | 478 |
| Cost of Goods | 97 | 74 | 75 | 72 | 67 |
| Gross Profit | 570 | 538 | 572 | 459 | 410 |
| Operating Expenses | 2,318 | 2,818 | 2,479 | 2,160 | 3,500 |
| Operating Income | -1,651 | -2,207 | -1,832 | -1,628 | -3,022 |
| Interest Expense | 65 | 81 | 257 | 17 | 103 |
| Other Income | -39 | -630 | -31 | 53 | -5,501 |
| Pre-tax Income | -1,755 | -2,918 | -2,121 | -1,592 | -8,625 |
| Net Income Continuous | -1,755 | -2,918 | -2,121 | -1,592 | -8,625 |
| Net Income | $-1,755 | $-2,918 | $-2,121 | $-1,592 | $-8,625 |
| EPS Basic Total Ops | -0.25 | -0.42 | -0.32 | 0.27 | -2.38 |
| EPS Basic Continuous Ops | -0.24 | -0.42 | -0.32 | 0.08 | -2.38 |
| EPS Diluted Total Ops | -0.25 | -0.42 | -0.32 | 0.27 | -2.38 |
| EPS Diluted Continuous Ops | -0.24 | -0.42 | -0.32 | 0.08 | -2.38 |
| EPS Diluted Before Non-Recurring Items | -0.25 | -0.42 | -0.32 | 0.29 | N/A |
| EBITDA(a) | $-1,601 | $-2,132 | $-1,800 | $-1,618 | $-1,681 |